Eiger BioPharmaceuticals News

Eiger BioPharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Oct 1 18:35

Eiger BioPharmaceuticals | 8-K: Current report

Oct 1 18:21

Eiger BioPharmaceuticals | 8-K: Current report

Sep 10 04:21

Eiger BioPharmaceuticals | 8-K: Current report

Sep 4 18:36

Eiger BioPharmaceuticals | 8-K: Current report

Sep 3 18:20

Eiger BioPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Moshe Arkin(10.09%)

Aug 26 22:06

Eiger BioPharmaceuticals | 8-K: Current report

Aug 3 04:20

Eiger BioPharmaceuticals | 8-K: Current report

Aug 1 18:31

Eiger BioPharmaceuticals | 8-K: Current report

Jul 16 18:17

Eiger BioPharmaceuticals | 8-K: Current report

Jul 10 20:19

Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(3.58%)

Jul 1 18:49

Eiger BioPharmaceuticals | 8-K: Current report

Jul 1 18:09

Eiger BioPharmaceuticals | 8-K: Current report

Jun 22 04:38

Eiger BioPharmaceuticals | 8-K: Current report

Jun 14 20:34

Eiger BioPharmaceuticals | 8-K: Current report

May 28 18:11

Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ameriprise Financial, Inc.(0.00%),Columbia Management Investment Advisers, LLC(0.00%), etc.

May 11 02:19

Eiger BioPharmaceuticals | 8-K: Current report

May 9 05:06

Eiger BioPharmaceuticals | 8-K: Current report

May 3 04:39

Eiger BioPharmaceuticals | 10-K/A: Annual report (Amendment)

Apr 30 04:49

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Apr 25 21:15